The FDA wants to place warning labels on food packages to combat obesity and other health conditions
The Food and Drug Administration (FDA) is looking to propose the inclusion of front-of-package warning labels that detail the ...
FDA to propose new food label warnings to combat obesity
The FDA is considering food labels to help consumers identify products with unhealthy ingredients, but some experts wonder if ...
Neu-REFIX Beta glucan receives rare pediatric disease and orphan drug designations from the US FDA for treatment of Duchenne Muscular Dystrophy
Neu refix granted orphan disease designation (ODD) & rare pediatric disease designation (RPDD) by US FDA for treatment of ...
STAT12h
FDA cites Granules, a large Indian generic drug manufacturer, for tossing truckloads of key documents
FDA cites Granules, a large Indian generic drug manufacturer, for tossing truckloads of important documents from a facility ...
Food Safety News4d
FDA warns food companies for violations in acidified foods and seafood imports
The Food and Drug Administration sends warning letters to entities under its jurisdiction as part of its enforcement ...
Following massive recalls and outbreaks, Americans are losing confidence in food safety regulations
A Gallup poll has found that consumers' confidence in food safety has dropped by 23 points between 2006 to 2024 ...
Scientific American14h
Obesity-Drug Pioneers Win Prestigious Lasker Award for Medical Science
Three scientists are honored for developing a class of blockbuster weight-loss drugs. Is a Nobel prize on the way?
USA Today4d
New eczema drug from Eli Lilly receives FDA approval for children and adults
On Friday, the U.S. Food and Drug Administration approved Eli Lilly's eczema drug for use in adults and children 12 ...
Senators Target Influencers, Telehealth Firms for Misleading Weight-Loss and Other Drug Promotion
The legislation would allow the FDA to warn and fine companies and individuals who post false information online about medications such as Ozempic and Wegovy.
Kisqali wins FDA nod for breast cancer treatment: Dosage, effectiveness and side effects of the breakthrough drug
The US FDA has approved Kisqali (ribociclib) for treating early-stage breast cancer in combination with hormone therapy. It ...